World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
62457
World Ranking
4147
National Ranking
2273

Overview

Michael H. Weisman is affiliated with Cedars-Sinai Medical Center in the United States and has contributed extensively to medical research, specifically within the field of medicine. Their work spans multiple subfields including rheumatology, immunology, hematology, epidemiology, and public health with a focus on environmental and occupational health. The breadth of their research reflects a concentration on autoimmune and inflammatory conditions as well as their treatment and pathogenesis.

The scientist's research topics prominently include:

  • Spondyloarthritis Studies and Treatments
  • Rheumatoid Arthritis Research and Therapies
  • Systemic Lupus Erythematosus Research
  • Psoriasis: Treatment and Pathogenesis
  • Autoimmune and Inflammatory Disorders Research
  • Pregnancy and Medication Impact
  • Inflammatory Bowel Disease

Michael H. Weisman's publication record demonstrates consistent contributions to key journals in rheumatology and related disciplines. Frequent publication venues include:

  • Annals of the Rheumatic Diseases
  • Rheumatic Disease Clinics of North America
  • Arthritis Care & Research
  • The Journal of Rheumatology
  • Arthritis & Rheumatology

Among selected recent papers authored or coauthored by Michael H. Weisman are:

  • "Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis," 2020, Annals of the Rheumatic Diseases
  • "Polygenic Risk Scores have high diagnostic capacity in ankylosing spondylitis," 2021, Annals of the Rheumatic Diseases
  • "Genomewide Association Study of Acute Anterior Uveitis Identifies New Susceptibility Loci," 2020, Investigative Ophthalmology & Visual Science
  • "Granzyme K activates the entire complement cascade," 2025, Nature
  • "Inflammatory Bowel Disease Prevalence: Surveillance data from the U.S. National Health and Nutrition Examination Survey," 2023, Preventive Medicine Reports

Frequent collaborators on Michael H. Weisman's research include:

  • John D. Reveille
  • Mariko Ishimori
  • Lianne S. Gensler
  • Michael M. Ward
  • Kevin D. Deane

Best Publications

  • Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus.

    Michelle Petri;Ana Maria Orbai;Graciela S. Alarcõn;Caroline Gordon

  • Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group.

    R Maini;E W St Clair;F Breedveld;D Furst

  • The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

    Ferdinand C Breedveld;Michael H Weisman;Arthur F Kavanaugh;Stanley B Cohen

  • Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial.

    Michael E. Weinblatt;Edward C. Keystone;Daniel E. Furst;Larry W. Moreland

  • Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis

    Daniel O. Clegg;Domenic J. Reda;Crystal L. Harris;Marguerite A. Klein

  • Association scan of 14,500 nonsynonymous SNPs in four diseases identifies autoimmunity variants

    Paul R Burton;David G Clayton;Lon R Cardon;Nick Craddock

  • Mycophenolate mofetil or intravenous cyclophosphamide for lupus nephritis

    Ellen M. Ginzler;Mary Anne Dooley;Cynthia Aranow;Mimi Y. Kim

  • New therapies for treatment of rheumatoid arthritis

    Josef S Smolen;Daniel Aletaha;Marcus Koeller;Michael H Weisman

  • Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010

    D. E. Furst;E. C. Keystone;J. Braun;F. C. Breedveld

  • Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis

    P Clements;P Lachenbruch;J Siebold;B White

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D M Evans;Spencer Cca.;J J Pointon;Z Su

  • Sustained benefits of infliximab therapy for dermatologic and articular manifestations of psoriatic arthritis: results from the infliximab multinational psoriatic arthritis controlled trial (IMPACT).

    Christian E. Antoni;Arthur Kavanaugh;Bruce Kirkham;Zuhre Tutuncu

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci.

    A Cortes;J Hadler;J P Pointon

  • Sustained improvement over two years in physical function, structural damage, and signs and symptoms among patients with rheumatoid arthritis treated with infliximab and methotrexate

    R. N. Maini;F. C. Breedveld;J. R. Kalden;J. S. Smolen

  • Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

    John D. Reveille;Anne Marie Sims;Patrick Danoy;David M. Evans

  • Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A department of veterans affairs cooperative study

    Daniel O. Clegg;Domenic J. Reda;Edwin Mejias;Grant W. Cannon

  • Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies.

    P. J. Clements;P. A. Lachenbruch;J. R. Seibold;B. Zee

  • Interaction between ERAP1 and HLA-B27 in ankylosing spondylitis implicates peptide handling in the mechanism for HLA-B27 in disease susceptibility

    D.M. Evans;C.C.A. Spencer;J.J. Pointon;Z. Su

  • Identification of multiple risk variants for ankylosing spondylitis through high-density genotyping of immune-related loci

    A. Cortes;J. Hadler;J.P. Pointon;P.C. Robinson

  • Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci

    J. D. Reveille;A. M. Sims;P. Danoy;D. M. Evans

Frequent Co-Authors

Daniel J. Wallace
Daniel J. Wallace Cedars-Sinai Medical Center
John D. Reveille
John D. Reveille The University of Texas Health Science Center at Houston
Matthew A. Brown
Matthew A. Brown Guy's and St Thomas' NHS Foundation Trust
Daniel E. Furst
Daniel E. Furst University of California, Los Angeles
Perry M. Nicassio
Perry M. Nicassio University of California, Los Angeles
Jill M. Norris
Jill M. Norris University of Colorado Anschutz Medical Campus
John B. Harley
John B. Harley United States Department of Veterans Affairs
Michael M. Ward
Michael M. Ward National Institutes of Health
Robert D. Inman
Robert D. Inman University of Toronto
Larry W. Moreland
Larry W. Moreland University of Colorado Anschutz Medical Campus

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a career in medicine offers a wide range of alternative and complementary educational options. Many students interested in healthcare explore related degrees that can be obtained online, expanding their career possibilities and improving work-life balance. Affordable tuition is often a key consideration, which is why researching the cheapest online healthcare administration degree programs is beneficial for those seeking administrative or leadership roles in medical settings.

For those aiming for advanced credentials, the cheapest online master degree in healthcare administration programs provide a cost-effective pathway to boost your career prospects in medical management. Nursing professionals may be interested in the least expensive dnp programs available online, helping them achieve the highest clinical proficiency without incurring heavy student debt.

Additionally, individuals interested in pharmaceuticals should explore opportunities for an online pharmacy degree. These flexible programs can open doors to both clinical and research roles within the field of pharmacy. Exploring these varied and affordable online degrees can help you find a healthcare career that aligns with your goals, schedule, and budget.

Best Scientists Citing Michael H. Weisman

Trending Scientists

Recently Published Articles